A Phase II trial of Ofatumumab in patients with lymphoma of the of the mucosa associated lymphoid tissue (MALT-Lymphoma) (O-MA 1)

Trial Profile

A Phase II trial of Ofatumumab in patients with lymphoma of the of the mucosa associated lymphoid tissue (MALT-Lymphoma) (O-MA 1)

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Ofatumumab (Primary)
  • Indications MALT lymphoma
  • Focus Therapeutic Use
  • Acronyms O-MA1
  • Most Recent Events

    • 29 Sep 2016 Status changed from recruiting to completed.
    • 29 Sep 2015 Interim results of 13 patients were presented at the European Cancer Congress 2015.
    • 09 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top